Birmingham, West Midlands -- (SBWIRE) -- 01/28/2014 -- Value Penny Stocks issues special report on DryShips Inc. (NASDAQ:DRYS), Zynga Inc (NASDAQ:ZNGA), Novavax, Inc. (NASDAQ:NVAX), Dynavax Technologies Corporation (NASDAQ:DVAX).
DryShips Inc. (NASDAQ:DRYS) ended its recent business day with the gain of 0.59% and closed at the price of $3.40 after opening at $3.31. The stock traded during its last trading session with the total volume of 13.23 million shares, as compared to its average volume of 18.09 million shares. DryShips Inc. owns drybulk carriers and tankers that operate worldwide. The company, through its majority owned subsidiary, Ocean Rig, owns and operates 10 offshore ultra deepwater drilling units.
Will DRYS Continue To Move Higher? Find Out Here
Zynga Inc (NASDAQ:ZNGA) remained among the day decliners and traded with volume of 12.59 million shares in the last session, as compared to average volume of 16.32 million shares. In comparison with 52 week range of $2.45 - $4.55, it faced lowest price of $3.37 during the last trading session whereas its day highest price was $3.51. The company’s total market capitalization is $2.75 billion, along with 804.35 million shares outstanding. Zynga Inc. develops, markets, and operates online social games as live services on the Internet, social networking sites, and mobile platforms in the United States and internationally.
Has ZNGA Found The Bottom And Ready To Gain Momentum? Find Out Here
Novavax, Inc. (NASDAQ:NVAX) showed 12.56 million shares in volume during the last trading session, while the average trading volume remained 6.03 million shares. The stock kicked off its trading session at $6.14 and closed at $5.73 after declining -8.32%. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company’s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines.
Why Should Investors Buy NVAX After the Recent Fall? Just Go Here and Find Out
Dynavax Technologies Corporation (NASDAQ:DVAX) stock traded during its last trading session with the total traded volume of 11.73 million shares versus its average volume of 5.25 million shares. The company opened its trade at the price of $1.85 and its closing price was $1.77 after losing -4.84% for the day. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences.
Will DVAX Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)